DE602005004393D1 - Verfahren zur asymmetrischen hydrierung, das sich für die herstellung von cycloalkanindolderivaten eignet - Google Patents

Verfahren zur asymmetrischen hydrierung, das sich für die herstellung von cycloalkanindolderivaten eignet

Info

Publication number
DE602005004393D1
DE602005004393D1 DE602005004393T DE602005004393T DE602005004393D1 DE 602005004393 D1 DE602005004393 D1 DE 602005004393D1 DE 602005004393 T DE602005004393 T DE 602005004393T DE 602005004393 T DE602005004393 T DE 602005004393T DE 602005004393 D1 DE602005004393 D1 DE 602005004393D1
Authority
DE
Germany
Prior art keywords
cycloalkanindol
derivatives
preparation
asymmetric hydrogenation
hydrogenation suitable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602005004393T
Other languages
English (en)
Other versions
DE602005004393T2 (de
Inventor
David M Tellers
Guy R Humphrey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE602005004393D1 publication Critical patent/DE602005004393D1/de
Application granted granted Critical
Publication of DE602005004393T2 publication Critical patent/DE602005004393T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B53/00Asymmetric syntheses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/94[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Indole Compounds (AREA)
  • Catalysts (AREA)
DE602005004393T 2004-04-02 2005-03-29 Verfahren zur asymmetrischen hydrierung, das sich für die herstellung von cycloalkanindolderivaten eignet Expired - Lifetime DE602005004393T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55897204P 2004-04-02 2004-04-02
US558972P 2004-04-02
PCT/US2005/010501 WO2005097745A1 (en) 2004-04-02 2005-03-29 Asymmetric hydrogenation process useful for the preparation of cycloalkanoindole derivatives

Publications (2)

Publication Number Publication Date
DE602005004393D1 true DE602005004393D1 (de) 2008-03-06
DE602005004393T2 DE602005004393T2 (de) 2009-01-08

Family

ID=34964828

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005004393T Expired - Lifetime DE602005004393T2 (de) 2004-04-02 2005-03-29 Verfahren zur asymmetrischen hydrierung, das sich für die herstellung von cycloalkanindolderivaten eignet

Country Status (19)

Country Link
US (1) US7576118B2 (de)
EP (1) EP1737820B1 (de)
JP (1) JP5239071B2 (de)
CN (1) CN1942440B (de)
AR (1) AR048459A1 (de)
AT (1) ATE384046T1 (de)
AU (1) AU2005230897B2 (de)
BR (1) BRPI0509384A (de)
CA (1) CA2561632A1 (de)
CY (1) CY1107223T1 (de)
DE (1) DE602005004393T2 (de)
DK (1) DK1737820T3 (de)
ES (1) ES2297695T3 (de)
HR (1) HRP20080145T3 (de)
PL (1) PL1737820T3 (de)
PT (1) PT1737820E (de)
SI (1) SI1737820T1 (de)
TW (1) TWI344954B (de)
WO (1) WO2005097745A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8580841B2 (en) 2008-07-23 2013-11-12 Arena Pharmaceuticals, Inc. Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders
CN105816453B (zh) 2008-08-27 2021-03-05 艾尼纳制药公司 用于治疗自身免疫性病症和炎性病症的作为s1p1受体激动剂的经取代的三环酸衍生物
SG182610A1 (en) 2010-01-27 2012-08-30 Arena Pharm Inc Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
CA2789480A1 (en) 2010-03-03 2011-09-09 Arena Pharmaceuticals, Inc. Processes for the preparation of s1p1 receptor modulators and crystalline forms thereof
CN102659664B (zh) * 2012-03-28 2015-01-21 中国计量学院 合成分离拉洛皮兰及其类似物的方法
US11007175B2 (en) 2015-01-06 2021-05-18 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the S1P1 receptor
BR112017027656B1 (pt) 2015-06-22 2023-12-05 Arena Pharmaceuticals, Inc. Hábito cristalino de placa livre de sal de l-arginina de ácido (r)-2-(7-(4- ciclopentil-3-(trifluorometil)benzilóxi)- 1,2,3,4-tetra-hidrociclo-penta[b]indol-3- il)acético, composição farmacêutica que o compreende, seus usos e método de preparação do mesmo
CA3053418A1 (en) 2017-02-16 2018-08-23 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of primary biliary cholangitis
JP2020507610A (ja) 2017-02-16 2020-03-12 アリーナ ファーマシューティカルズ, インコーポレイテッド 腸管外症状を伴う炎症性腸疾患の治療のための化合物および方法
BR112020024762A2 (pt) 2018-06-06 2021-03-23 Arena Pharmaceuticals, Inc. métodos de tratamento de condições relacionadas ao receptor s1p1
CN119751336A (zh) 2018-09-06 2025-04-04 艾尼纳制药公司 可用于治疗自身免疫性病症和炎性病症的化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0272787B1 (de) 1986-11-14 1992-05-06 Takasago International Corporation Katalytische Produktion von optisch aktiven Carbonsäuren
AR038136A1 (es) * 2002-01-24 2004-12-29 Merck Frosst Canada Inc Cicloalcanindoles con sustitucion con fluor composiciones que contienen estos compuestos y metodos de tratamiento
ATE464048T1 (de) * 2003-08-07 2010-04-15 Merck Sharp & Dohme Behandlung von alzheimer-krankheit und verwandten zuständen

Also Published As

Publication number Publication date
JP5239071B2 (ja) 2013-07-17
EP1737820A1 (de) 2007-01-03
PT1737820E (pt) 2008-03-17
CN1942440B (zh) 2011-09-14
DK1737820T3 (da) 2008-04-28
SI1737820T1 (sl) 2008-04-30
ATE384046T1 (de) 2008-02-15
ES2297695T3 (es) 2008-05-01
US20050222428A1 (en) 2005-10-06
AU2005230897A1 (en) 2005-10-20
CA2561632A1 (en) 2005-10-20
CN1942440A (zh) 2007-04-04
TW200606145A (en) 2006-02-16
DE602005004393T2 (de) 2009-01-08
US7576118B2 (en) 2009-08-18
PL1737820T3 (pl) 2008-05-30
HRP20080145T3 (en) 2008-04-30
AR048459A1 (es) 2006-04-26
BRPI0509384A (pt) 2007-09-18
JP2007532488A (ja) 2007-11-15
TWI344954B (en) 2011-07-11
AU2005230897B2 (en) 2011-03-03
CY1107223T1 (el) 2012-11-21
WO2005097745A1 (en) 2005-10-20
EP1737820B1 (de) 2008-01-16

Similar Documents

Publication Publication Date Title
DE602005009866D1 (de) Verfahren zur herstellung von n-phenylpyrazol-1-carboxamiden
DE502006000218D1 (de) Verfahren zur Herstellung von SiOC-verknüpften, linearen Polydialkylsiloxan-Polyoxyalkylen-Blockcopolymeren
DE602005026987D1 (de) Verfahren zur herstellung von 1,2-dichlorethan
DE502005002059D1 (de) Verfahren zur herstellung von polyetheralkoholen
DE602005019848D1 (de) Verfahren zur herstellung von tad- getrocknetem ti
DE602006010132D1 (de) Zwischenprodukte für die Herstellung von Trans-5-Chlor-2-Methyl-2,3,3a,12b-Tetrahydro-1h-DibenzÄ2,3:6,7ÜOxepinoÄ4,5-cÜPyrrol
DE502005010038D1 (de) Verfahren zur herstellung von 3-pentennitril
ATE468754T1 (de) Verbessertes verfahren für die herstellung von tee
DE502006000138D1 (de) Verfahren zur Herstellung von Triorganosiloxygruppen aufweisenden Organopolysiloxanen
ATE308524T1 (de) Verfahren zur herstellung von aripiprazole
DE602005007734D1 (de) Verfahren zur herstellung von telmisartan
DE602005004393D1 (de) Verfahren zur asymmetrischen hydrierung, das sich für die herstellung von cycloalkanindolderivaten eignet
ATE376997T1 (de) Verfahren zur herstellung von 1,4- diphenylazetidinon-derivaten
DE602005014280D1 (de) Verfahren zur herstellung von ä1,4,5ü-oxadiazepinderivaten
ATE466843T1 (de) Verfahren zur herstellung von n-piperidino-1,5- diphenylpyrazol-3-carboxamid-derivaten
DE602004004677D1 (de) Verfahren zur herstellung substituierter 5-amino-pyrazolo-ä4,3-eü-1,2,4-triazoloä1,5-cüpyrimidine
DE602005011814D1 (de) Verfahren zur herstellung von enantiomerreinen 1,1'-spirobiindan-6,6'-diol-derivaten
DE502006004187D1 (de) Verfahren zur herstellung von diorganopolysiloxanen
DE502005007702D1 (de) Verfahren zur herstellung von terrylen-3,4:11,12-t
DE602004004777D1 (de) Kontinuierliches verfahren für die herstellung von polyamiden
ATE549314T1 (de) Verfahren zur herstellung von 4-aminochinazolinen
DE60336173D1 (de) Verfahren zur herstellung von vanadylpyrophosphat-katalysatoren
DE602005023028D1 (de) VERFAHREN ZUR HERSTELLUNG VON 11-(4-Ä2-(2-HYDROXYETHOXY)ETHYLÜ-1-PIPERAZINYL)DIBENZOÄb,fÜÄ1,4ÜTHIAZEPIN
DE502005000184D1 (de) Verfahren zur Herstellung von linearen Si-H-Gruppen aufweisenden Organopolysiloxanen
EP1720840A4 (de) Verfahren zur herstellung von 1,3-dioxolannukleosiden

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: MERCK & CO., INC., RAHWAY, N.J., US

8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: MERCK SHARP & DOHME CORP., RAHWAY, N.J., US

8328 Change in the person/name/address of the agent

Representative=s name: MARKS & CLERK (LUXEMBOURG) LLP, LUXEMBOURG, LU

R081 Change of applicant/patentee

Ref document number: 1737820

Country of ref document: EP

Owner name: SCHERING CORPORATION, US

Free format text: FORMER OWNER: MERCK SHARP & DOHME CORP., RAHWAY, US

Effective date: 20121213

R082 Change of representative

Ref document number: 1737820

Country of ref document: EP

Representative=s name: MARKS & CLERK (LUXEMBOURG) LLP, LU

Effective date: 20121213